ReArmor - VR therapy Tool

Scroll

Overview

ReArmor™, a pioneering virtual reality authoring platform developed in collaboration between Terasynth and the University of Central Florida, represents a cutting-edge advancement in clinical PTSD treatment.

This innovative tool empowers clinicians to harness VR therapy and real-time physiological tracking to create personalized exposure therapy sessions, particularly targeting first responders grappling with post-traumatic stress disorder. With a focus on customization and efficacy, ReArmor™ offers a suite of features including physiological tracking, a HIPAA compliant clinician portal, integration with a medical-grade Meta Quest Pro VR headset, compatibility with Google Fitbit watches, a specialized VR software application, and a web interface software component.

By leveraging state-of-the-art technology, ReArmor™ revolutionizes PTSD treatment with exceptional outcomes that surpass traditional VA treatment methods.

Scroll

Technical Specifications

In terms of technical specifications, ReArmor™ showcases a range of innovative features that set it apart as a transformative tool in clinical PTSD treatment.

Notable technical components of ReArmor™ include advanced physiological tracking and reporting capabilities, a secure HIPAA compliant portal designed for clinicians, seamless integration with the medical-grade Meta Quest Pro VR headset, compatibility with Google Fitbit watches for enhanced tracking, a specialized VR software application, and a web interface software component. These specifications collectively enable clinicians to design and implement personalized, photorealistic traumatic scenarios for exposure therapy sessions tailored to the unique needs of first responders suffering from PTSD.

By prioritizing technical excellence and customization, ReArmor™ emerges as a powerful solution at the forefront of innovative PTSD treatment methods.

Scroll

Case Study

ReArmor™ stands as a compelling case study in the realm of virtual reality-driven PTSD treatment, exemplifying the collaborative efforts of Terasynth and the University of Central Florida in developing a transformative solution.

Through the convergence of VR therapy, real-time physiological tracking, and innovative software components, ReArmor™ empowers clinicians to craft personalized exposure therapy sessions for first responders battling PTSD. This case study highlights the profound potential impact of ReArmor™, as evidenced by UCF's extensive 13-year research and development backing its unparalleled efficacy in treating PTSD.

By surpassing traditional VA treatment methods, ReArmor™ has led to a notable percentage of participants no longer meeting diagnostic criteria for PTSD post-treatment, advancing clinical PTSD treatment practices.

CAGE: 9FCY9 / NAICS: 541511, 541512, 541330, 518210, 541690

ORLANDO, FLORIDA USA

© 2024 Terasynth, the Terasynth logo, ReArmor™, the ReArmor™ logo, Earthcloned™, the Earthcloned™ logo, and Anya™ artificial intelligence are trademarks or registered trademarks of Terasynth, Inc. in the United States of America and elsewhere. All rights reserved.

CAGE: 9FCY9 / NAICS: 541511, 541512, 541330, 518210, 541690

ORLANDO, FLORIDA USA

© 2024 Terasynth, the Terasynth logo, ReArmor™, the ReArmor™ logo, Earthcloned™, the Earthcloned™ logo, and Anya™ artificial intelligence are trademarks or registered trademarks of Terasynth, Inc. in the United States of America and elsewhere. All rights reserved.

CAGE: 9FCY9 / NAICS: 541511, 541512, 541330, 518210, 541690

ORLANDO, FLORIDA USA

© 2024 Terasynth, the Terasynth logo, ReArmor™, the ReArmor™ logo, Earthcloned™, the Earthcloned™ logo, and Anya™ artificial intelligence are trademarks or registered trademarks of Terasynth, Inc. in the United States of America and elsewhere. All rights reserved.